| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q4 2021 Pre-Market | EPS: REV: | ||||
| Q4 2021 After-Hours | EPS: REV: | ||||
| Q3 2021 After-Hours | EPS: REV: | 0.39 1.818B | |||
| Q3 2021 Pre-Market | EPS: REV: | 0.59 155.002M | |||
| Q2 2021 After-Hours | EPS: REV: | ||||
| Q2 2021 Pre-Market | EPS: REV: | ||||
| Q1 2021 After-Hours | EPS: REV: | 0.45 1.822B | |||
| Q1 2021 Pre-Market | EPS: REV: | -0.62 85.097M | |||
| Q4 2020 Pre-Market | EPS: REV: | 0.52 168.985M | 0.44 148.55M | 0.78 154.291M | 77.27% 3.86% |
| Q4 2020 After-Hours | EPS: REV: | 0.45 1.881B | 0.41 1.89B | 0.41 1.925B | 0% 1.85% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- MoneyLion Announces 2020 Results, Q1 Preview Ahead Of Listing
- Mid-Afternoon Market Update: Gold Jumps 1.8%; Dell Shares Spike Higher
- Bank Of America And Citigroup Struggle After Stellar Q1 Earnings
- Mid-Day Market Update: Dow Surges 250 Points; KLX Energy Services Shares Slide
- Which Bank Stock Is The Best Buy Right Now?
- ROCE Insights For United Parcel Service
- ROCE Insights For American Eagle Outfitters
- Return On Capital Employed Overview: CrowdStrike Holdings
- Return On Capital Employed Overview: Thermo Fisher Scientific
- ROCE Insights For Marsh & McLennan
